3/11
02:12 pm
srpt
Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D [Yahoo! Finance]
Low
Report
Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D [Yahoo! Finance]
3/8
05:56 am
srpt
Got $1,000? Buy These Hot Growth Stocks Before They Take Off. [Yahoo! Finance]
Low
Report
Got $1,000? Buy These Hot Growth Stocks Before They Take Off. [Yahoo! Finance]
3/7
12:13 am
srpt
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT) [Yahoo! Finance]
Low
Report
Director Stephen Mayo Sells 3,135 Shares of Sarepta Therapeutics Inc (SRPT) [Yahoo! Finance]
3/5
06:21 pm
srpt
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating.
Low
Report
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) was upgraded by analysts at TheStreet from a "d" rating to a "c-" rating.
3/4
09:57 am
srpt
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]
Low
Report
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst [Yahoo! Finance]
3/4
09:11 am
srpt
Science Continues To Outpace Commercialization Of Cell And Gene Therapies [Forbes]
Low
Report
Science Continues To Outpace Commercialization Of Cell And Gene Therapies [Forbes]
3/4
08:30 am
srpt
Sarepta Therapeutics to Present at Upcoming Investor Conferences
Low
Report
Sarepta Therapeutics to Present at Upcoming Investor Conferences
3/2
07:28 am
srpt
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
Medium
Report
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report [Yahoo! Finance]
2/28/2024
04:05 pm
srpt
sarepta therapeutics, inc.
BEAT
Report
-8.6%
sarepta therapeutics, inc.
11/1/2023
04:05 pm
srpt
sarepta therapeutics, inc.
BEAT
Report
-0.3%
sarepta therapeutics, inc.
8/2/2023
04:05 pm
srpt
sarepta therapeutics, inc.
BEAT
Report
4.7%
sarepta therapeutics, inc.
5/2/2023
04:05 pm
srpt
sarepta therapeutics, inc.
BEAT
Report
4.5%
sarepta therapeutics, inc.
3/11
08:03 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 08 Filed by: Wigzell Hans Lennart Rudolf
Low
Report
Form 4 Sarepta Therapeutics, For: Mar 08 Filed by: Wigzell Hans Lennart Rudolf
3/11
08:01 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Arif Bilal
Low
Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Arif Bilal
3/11
08:01 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Boor Kathryn Jean
Low
Report
Form 4 Sarepta Therapeutics, For: Mar 11 Filed by: Boor Kathryn Jean
3/11
08:01 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Rodino-Klapac Louise
Low
Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Rodino-Klapac Louise
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Brown Ryan Edward
Low
Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Brown Ryan Edward
3/11
08:00 pm
srpt
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Estepan Ian Michael
Low
Report
Form 4 Sarepta Therapeutics, For: Mar 07 Filed by: Estepan Ian Michael
3/11
07:04 pm
srpt
Form 144 Sarepta Therapeutics, Filed by: Boor Kathryn Jean
Low
Report
Form 144 Sarepta Therapeutics, Filed by: Boor Kathryn Jean
3/8
05:39 pm
srpt
Form 144 Sarepta Therapeutics, Filed by: Wigzell Hans Lennart Rudolf
Low
Report
Form 144 Sarepta Therapeutics, Filed by: Wigzell Hans Lennart Rudolf
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register